Trivium Point Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $386K | Sell |
|
|||||
|
2025
Q2 | $513K | Sell |
|
|||||
|
2025
Q1 | $688K | Buy |
|
|||||
|
2024
Q4 | $554K | Buy |
|
|||||
|
2024
Q3 | $461K | Buy |
|
|||||
|
2024
Q2 | $302K | Buy |
|
|||||
|
2024
Q1 | $333K | Buy |
|
|||||
|
2023
Q4 | $239K | Sell |
|
|||||
|
2023
Q3 | $281K | Sell |
|
|||||
|
2023
Q2 | $317K | Sell |
|
|||||
|
2023
Q1 | $362K | Sell |
|
|||||
|
2022
Q4 | $385K | Sell |
|
|||||
|
2022
Q3 | $373K | Sell |
|
|||||
|
2022
Q2 | $419K | Sell |
|
|||||
|
2022
Q1 | $559K | Sell |
|
|||||
|
2021
Q4 | $494K | Buy |
|
|||||
|
2021
Q3 | $413K | Sell |
|
|||||
|
2021
Q2 | $1.59M | Sell |
|
|||||
|
2021
Q1 | $1.66M | Sell |
|
|||||
|
2020
Q4 | $1.81M | Sell |
|
|||||
|
2020
Q3 | $1.84M | Sell |
|
|||||
|
2020
Q2 | $1.91M | Buy |
|
|||||
|
2020
Q1 | $435K | Buy |
|
|||||
|
2019
Q4 | $240K | Sell |
|
|||||
|
2019
Q3 | $243K | Buy |
|
|||||
|
2019
Q2 | $202K | Sell |
|
|||||
|
2019
Q1 | $230K | Buy |
|
|||||
|
2018
Q4 | $209K | Buy |
|